focus -WSS

focus

author：Wikipedia 2025-08-26 23:48:04 - browse：15

Photograph of Bill Cassidy. -- health policy coverage from STAT — Sen. Bill Cassidy (R-La.) Kevin Dietsch/Getty Images

WASHINGTON — With Novo Nordisk’s Wegovy and Ozempic hitting blockbuster sales and a new rival approved this week, everyone in Washington is thinking about how to manage the crashing wave of weight loss drug costs.

The explosive national demand for weight management therapies and diabetes drugs like Ozempic — all of which are indicated for indefinite use — has become central in an ongoing policy debate over high drug costs and controversial tactics to manage them, including President Biden’s plan to let the government negotiate directly with pharmaceutical companies. Seventy percent of Americans could qualify for these medicines.

Sen. Bill Cassidy (R-La.), the highest-ranking Republican on the Senate’s health policy committee, has vehemently opposed the negotiation plan, arguing it reduces incentives to develop new therapies and may not actually reduce patients’ costs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： A new drug could help frostbite victims avoid its ravages

leisure time

WSS

Clinic falsely told dozens they had Alzheimer's, suits say

Burning questions about Delta and the next phase of the Covid pandemic

Clinic falsely told dozens they had Alzheimer's, suits say

4 missing after record

In 'major milestone,' FDA approves first cell therapy for solid tumors

Opioid cravings were reduced by anti

focus

focus

knowledge

BioMarin wins approval for gene therapy to treat hemophilia A

How a key Senate committee is planning to regulate PBMs

DIEP, the 'gold standard' of breast reconstruction, is under threat

Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

New air purifier tech could be key to improving indoor air quality

My chronic pain journey would have been easier knowing 5 things % STAT

23andMe had bad news about my health. I wish a person had delivered it

As AI regulations shape up, health tech startups beg for clarity

How to save PrEP access — and even expand it

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

focus

Severe heat forecast: Where scorching temperatures will persist over the next week

New CMS data security rules will hurt Medicare, Medicaid research

Thousands protest mob assault of women who were paraded naked in remote Indian border state

Inside the culture of fear in the White House science office of Eric Lander

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

Weight loss drugs aren’t covered by Obamacare. That may change

hotspot

leisure time

Wikipedia

explore